TRANSACTION AND BUSINESS COMBINATION - Common Stock in Innovid Corp (Details) - shares |
Nov. 30, 2021 |
Dec. 31, 2021 |
Dec. 31, 2020 |
|---|---|---|---|
| Business Acquisition [Line Items] | |||
| Common stock, shares outstanding (in shares) | 119,017,380 | 16,275,609 | |
| Innovid Corp | |||
| Business Acquisition [Line Items] | |||
| Common stock, shares outstanding (in shares) | 16,275,609 | ||
| Warrant exercised (in shares) | 132,392 | ||
| Stock options exercised (in shares) | 3,180,943 | ||
| Conversion of redeemable convertible preferred stock into common stock (in shares) | 73,690,340 | ||
| Conversion of Legacy Innovid warrants ( in shares) | 507,994 | ||
| Exchanged into Innovid Corp. common stock on November 30, 2021 (in shares) | 93,787,278 |
| X | ||||||||||
- Definition Stock Issued During Period, Share, Conversion of Warrants No definition available.
|
| X | ||||||||||
- Definition Stock Issued During Period, Shares, Reverse Recapitalization No definition available.
|
| X | ||||||||||
- Definition Stock Issued During Period, Shares, Warrant Exercised No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares issued during the period as a result of the conversion of convertible securities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of share options (or share units) exercised during the current period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|